Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MBRX Moleculin Biotech, Inc.

盘前交易 12-24 07:47:24 EST

1.73

+0.06

+3.59%

最高1.82	最低1.50	成交量32.97万
今开1.66	昨收1.67	日振幅19.16%
总市值552.03万	流通市值482.60万	总股本319.09万
成交额52.36万	换手率11.82%	流通股本278.96万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech, Inc.","latestPrice":1.73,"timestamp":1734987600000,"preClose":1.67,"halted":0,"volume":329701,"delay":0,"floatShares":2789600,"shares":3190899,"eps":-11.219237,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.06,"latestTime":"12-24 07:47:24 EST","open":1.66,"high":1.82,"low":1.5,"amount":523610.093276,"amplitude":0.191617,"askPrice":1.87,"askSize":100,"bidPrice":1.49,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-11.219237,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735050600000},"adr":0,"adjPreClose":1.73,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.73,"latestTime":"19:26 EST","volume":364,"amount":608.91,"timestamp":1734999967813},"volumeRatio":5.294933921010953},"requestUrl":"/m/hq/s/MBRX/wiki","defaultTab":"wiki","newsList":[{"id":"2493765136","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌5.39%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493765136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493765136?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:33","pubTimestamp":1734964425,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时33分，Moleculin Biotech, Inc.股票出现波动，股价快速下跌5.39%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为669.33%、445.60%、299.52%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.，振幅分别为39.04%、36.35%、33.81%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223345a2050b41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223345a2050b41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2493792944","title":"Moleculin Biotech, Inc.盘中异动 快速下跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493792944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493792944?lang=zh_cn&edition=full","pubTime":"2024-12-21 04:42","pubTimestamp":1734727355,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日04时42分，Moleculin Biotech, Inc.股票出现波动，股价大幅下挫6.08%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2762.45%、506.33%、134.12%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Abpro Holdings, Inc、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为178.59%、173.15%、134.00%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221044235984d0098&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221044235984d0098&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2492010538","title":"Moleculin Biotech, Inc.盘中异动 早盘急速跳水5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492010538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492010538?lang=zh_cn&edition=full","pubTime":"2024-12-20 00:07","pubTimestamp":1734624472,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日00时07分，Moleculin Biotech, Inc.股票出现波动，股价急速下挫5.55%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为1.74%。其相关个股中，Bio-Path Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Bio-Path Holdings, Inc.、Psyence Biomedical Ltd.、Elevai Labs, Inc.较为活跃，换手率分别为2072.82%、1120.94%、554.82%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为236.17%、172.75%、98.22%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220000752984cdb40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220000752984cdb40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2492957184","title":"Moleculin Biotech, Inc.盘中异动 快速拉升10.75%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492957184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492957184?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:33","pubTimestamp":1734532384,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时33分，Moleculin Biotech, Inc.股票出现异动，股价快速上涨10.75%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1012.77%、300.92%、241.07%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为66.83%、37.37%、24.76%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223304ab82070d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223304ab82070d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2491836697","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491836697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491836697?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:33","pubTimestamp":1734359602,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时33分，Moleculin Biotech, Inc.股票出现异动，股价快速跳水6.03%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为31.73%、29.40%、26.18%，振幅较大的相关个股有Genprex, Inc.、Tonix Pharmaceuticals Holding Corp.、Eterna Therapeutics Inc.，振幅分别为18.10%、13.80%、10.38%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121622332295ea134c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121622332295ea134c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2491937300","title":"Moleculin Biotech, Inc.盘中异动 股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491937300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491937300?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:31","pubTimestamp":1734100301,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时31分，Moleculin Biotech, Inc.股票出现波动，股价急速拉升5.49%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Mesoblast Ltd、Sangamo Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为23.26%、20.38%、14.76%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Sangamo Therapeutics, Inc.，振幅分别为13.56%、11.34%、9.42%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223141984bd676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223141984bd676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2490382902","title":"Moleculin Biotech, Inc.盘中异动 早盘快速跳水6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490382902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490382902?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:44","pubTimestamp":1734014699,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时44分，Moleculin Biotech, Inc.股票出现波动，股价急速下跌6.63%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Palisade Bio, Inc.、Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为2626.07%、60.14%、51.65%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Palisade Bio, Inc.、Trevi Therapeutics, Inc.，振幅分别为55.45%、45.71%、32.53%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224459a1e957ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224459a1e957ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2490186859","title":"Moleculin Biotech, Inc.股价上涨19.05% 市值涨157.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490186859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490186859?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:31","pubTimestamp":1733927519,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时31分，Moleculin Biotech, Inc.股票出现波动，股价快速上涨19.05%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为367.15%、106.89%、97.36%，振幅较大的相关个股有Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Tnf Pharmaceuticals, Inc.，振幅分别为19.09%、18.52%、18.15%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223200a1e66ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223200a1e66ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2490504981","title":"Moleculin Biotech, Inc.盘中异动 股价大跌5.43%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490504981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490504981?lang=zh_cn&edition=full","pubTime":"2024-12-11 01:10","pubTimestamp":1733850658,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时10分，Moleculin Biotech, Inc.股票出现波动，股价大幅跳水5.43%。截至发稿，该股报2.44美元/股，成交量1.3591万股，换手率0.45%，振幅4.65%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211011059a1e3dd99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211011059a1e3dd99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2489269576","title":"Moleculin Biotech, Inc.盘中异动 临近收盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489269576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489269576?lang=zh_cn&edition=full","pubTime":"2024-12-07 05:00","pubTimestamp":1733518808,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日05时00分，Moleculin Biotech, Inc.股票出现异动，股价急速拉升5.20%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Adc Therapeutics Sa、Surrozen Inc C/Wts 01/08/2031 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.、Molecular Templates, Inc.较为活跃，换手率分别为162.14%、115.75%、99.78%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为191.67%、99.12%、80.81%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207050008ab638dd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207050008ab638dd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2489499559","title":"Moleculin Biotech, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489499559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489499559?lang=zh_cn&edition=full","pubTime":"2024-12-06 02:18","pubTimestamp":1733422704,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日02时18分，Moleculin Biotech, Inc.股票出现波动，股价快速上涨5.18%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Protara Therapeutics, Inc.、Molecular Templates, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3516.89%、2330.10%、489.55%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Molecular Templates, Inc.、Protara Therapeutics, Inc.，振幅分别为136.00%、124.83%、106.21%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120602182498e5a7c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120602182498e5a7c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2488975348","title":"Moleculin Biotech, Inc.盘中异动 股价大跌5.20%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488975348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488975348?lang=zh_cn&edition=full","pubTime":"2024-12-04 04:35","pubTimestamp":1733258111,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日04时35分，Moleculin Biotech, Inc.股票出现异动，股价急速下挫5.20%。截至发稿，该股报2.55美元/股，成交量8156股，换手率0.27%，振幅4.09%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120404351198e52a88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120404351198e52a88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2488604863","title":"Moleculin Biotech, Inc.盘中异动 大幅下跌6.14%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488604863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488604863?lang=zh_cn&edition=full","pubTime":"2024-12-03 01:59","pubTimestamp":1733162347,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日01时59分，Moleculin Biotech, Inc.股票出现波动，股价快速跳水6.14%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2490.59%、2371.76%、633.82%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120301590898e4f268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120301590898e4f268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2485532440","title":"Moleculin Biotech, Inc.盘中异动 临近收盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485532440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485532440?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:31","pubTimestamp":1732221069,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时31分，Moleculin Biotech, Inc.股票出现异动，股价快速拉升5.62%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Briacell Therapeutics Corp.、Cidara Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为983.70%、549.04%、413.35%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Biodexa Pharmaceuticals Plc，振幅分别为162.20%、87.47%、84.16%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗高耐药性肿瘤和病毒的广泛候选药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122043109971a7f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122043109971a7f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2484812110","title":"Moleculin Biotech, Inc.盘中异动 早盘大幅上涨8.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484812110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484812110?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:30","pubTimestamp":1732113044,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时30分，Moleculin Biotech, Inc.股票出现异动，股价快速拉升8.60%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为436.04%、114.31%、87.80%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Alaunos Therapeutics, Inc.、Moleculin Biotech, Inc.，振幅分别为13.77%、10.94%、7.65%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗高耐药性肿瘤和病毒的广泛候选药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223044971a7aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223044971a7aa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2484297669","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484297669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484297669?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:34","pubTimestamp":1732030447,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时34分，Moleculin Biotech, Inc.股票出现波动，股价急速拉升5.36%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Tff Pharmaceuticals, Inc.、Exicure, Inc.、Hcw Biologics Inc.较为活跃，换手率分别为707.96%、111.56%、101.96%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为81.67%、62.18%、52.14%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗高耐药性肿瘤和病毒的广泛候选药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233407a2460da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233407a2460da0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2483863647","title":"Moleculin Biotech, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483863647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483863647?lang=zh_cn&edition=full","pubTime":"2024-11-14 05:00","pubTimestamp":1731531639,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日05时00分，Moleculin Biotech, Inc.股票出现异动，股价大幅下挫5.30%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为759.09%、584.21%、189.44%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.，振幅分别为140.00%、134.66%、86.83%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗高耐药性肿瘤和病毒的广泛候选药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111405003998e42760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111405003998e42760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2482360167","title":"Moleculin 生物技术公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482360167","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482360167?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:33","pubTimestamp":1731339205,"startTime":"0","endTime":"0","summary":"Moleculin 生物技术公司报告本季度业绩 - 收益摘要Moleculin Biotech Inc MBRX.OQ公布的季度调整后每股亏损为2.85美元，与去年同期持平。两位分析师对该季度的平均预期是每股亏损 2.44 美元。Moleculin Biotech Inc 报告的本季度每股收益为亏损 2.85 美元。该公司的季度亏损额为 1059 万美元。Moleculin Biotech Inc 的股价本季度下跌了 10.2%，今年迄今为止下跌了 80.2%。华尔街对 Moleculin Biotech Inc 的 12 个月目标价中位数为 30.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4T3MI13Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2482437163","title":"Moleculin Biotech, Inc.盘中异动 股价大涨5.06%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482437163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482437163?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:00","pubTimestamp":1731096038,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日04时00分，Moleculin Biotech, Inc.股票出现异动，股价大幅拉升5.06%。截至发稿，该股报2.46美元/股，成交量1.9602万股，换手率0.69%，振幅3.84%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗高耐药性肿瘤和病毒的广泛候选药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110904003898e418ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110904003898e418ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2481964590","title":"Moleculin Biotech Inc  预计每股亏损 2.44 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481964590","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481964590?lang=zh_cn&edition=full","pubTime":"2024-11-07 07:22","pubTimestamp":1730935327,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc  预计每股亏损 2.44 美元 - 财报前瞻Moleculin Biotech Inc MBRX.OQ MBRX.O预计在11月8日公布截至0001年1月1日的财报时，季度收入将没有变化。LSEG 的分析师平均预计 Moleculin Biotech Inc 每股亏损 2.44 美元。华尔街对 Moleculin Biotech Inc 的 12 个月目标价中位数为 30.00 美元，高于其上次收盘价 2.30 美元。11月6日 - 本摘要于北京时间 11 月 6 日 23:21 机器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD3LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moleculin.com","stockEarnings":[{"period":"1week","weight":-0.21},{"period":"1month","weight":-0.3663},{"period":"3month","weight":-0.3569},{"period":"6month","weight":-0.4986},{"period":"1year","weight":-0.8304},{"period":"ytd","weight":-0.8656}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司，着眼于开发抗癌药物的研发，主要与德克萨斯州大学的M.D. Anderson癌症中心合作。该公司的主要研制药品是脂质的安那霉素，用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物，一是WP1066药物，主要控制参与癌症的关键转录调控因子；二是WP1122药物，主要通过分子靶来影响癌症细胞的代谢过程。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.042816},{"month":2,"riseRate":0.25,"avgChangeRate":-0.069703},{"month":3,"riseRate":0.25,"avgChangeRate":-0.110793},{"month":4,"riseRate":0.375,"avgChangeRate":0.078127},{"month":5,"riseRate":0.125,"avgChangeRate":-0.061505},{"month":6,"riseRate":0.25,"avgChangeRate":0.124538},{"month":7,"riseRate":0.555556,"avgChangeRate":0.074026},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.100133},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.080426},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.142911},{"month":11,"riseRate":0.555556,"avgChangeRate":0.056416},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.06378}],"exchange":"NASDAQ","name":"Moleculin Biotech, Inc.","nameEN":"Moleculin Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moleculin Biotech, Inc.,MBRX,Moleculin Biotech, Inc.股票,Moleculin Biotech, Inc.股票老虎,Moleculin Biotech, Inc.股票老虎国际,Moleculin Biotech, Inc.行情,Moleculin Biotech, Inc.股票行情,Moleculin Biotech, Inc.股价,Moleculin Biotech, Inc.股市,Moleculin Biotech, Inc.股票价格,Moleculin Biotech, Inc.股票交易,Moleculin Biotech, Inc.股票购买,Moleculin Biotech, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}